165 related articles for article (PubMed ID: 38442323)
21. Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province : Using algorithms to determine breast and colorectal cancer recurrence.
Lambert P; Pitz M; Singh H; Decker K
BMC Cancer; 2021 Jul; 21(1):763. PubMed ID: 34210266
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data.
Stein JD; Rahman M; Andrews C; Ehrlich JR; Kamat S; Shah M; Boese EA; Woodward MA; Cowall J; Trager EH; Narayanaswamy P; Hanauer DA
JAMA Ophthalmol; 2019 May; 137(5):491-497. PubMed ID: 30789656
[TBL] [Abstract][Full Text] [Related]
23. Identifying lupus patients in electronic health records: Development and validation of machine learning algorithms and application of rule-based algorithms.
Jorge A; Castro VM; Barnado A; Gainer V; Hong C; Cai T; Cai T; Carroll R; Denny JC; Crofford L; Costenbader KH; Liao KP; Karlson EW; Feldman CH
Semin Arthritis Rheum; 2019 Aug; 49(1):84-90. PubMed ID: 30665626
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
[TBL] [Abstract][Full Text] [Related]
25. Detection of Diabetes Status and Type in Youth Using Electronic Health Records: The SEARCH for Diabetes in Youth Study.
Wells BJ; Lenoir KM; Wagenknecht LE; Mayer-Davis EJ; Lawrence JM; Dabelea D; Pihoker C; Saydah S; Casanova R; Turley C; Liese AD; Standiford D; Kahn MG; Hamman R; Divers J
Diabetes Care; 2020 Oct; 43(10):2418-2425. PubMed ID: 32737140
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography in the management of documented or suspected recurrent ovarian cancer.
Chou HH; Chen CY; Liu FY; Lin G; Wang CC; Yang LY; Chen MY; Pan YB; Wu RC; Yen TC; Chang TC; Lai CH
J Formos Med Assoc; 2017 Nov; 116(11):869-879. PubMed ID: 28089190
[TBL] [Abstract][Full Text] [Related]
27. The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Omarov N; Uymaz DS; Kulle CB; Ozkan ZG; Azamat S; Keskin M; Bulut MT
Pol Przegl Chir; 2022 Feb; 94(6):10-16. PubMed ID: 36468505
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
[TBL] [Abstract][Full Text] [Related]
29. A cost-effective chart review sampling design to account for phenotyping error in electronic health records (EHR) data.
Yin Z; Tong J; Chen Y; Hubbard RA; Tang CY
J Am Med Inform Assoc; 2021 Dec; 29(1):52-61. PubMed ID: 34718618
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
31. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Thrall MM; DeLoia JA; Gallion H; Avril N
Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
[TBL] [Abstract][Full Text] [Related]
33. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
Li X; Wang L; Guo P; Sun Q; Zhang Y; Chen C; Zhang Y
Ann Nucl Med; 2023 Oct; 37(10):541-550. PubMed ID: 37422857
[TBL] [Abstract][Full Text] [Related]
35. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer.
Murakami M; Miyamoto T; Iida T; Tsukada H; Watanabe M; Shida M; Maeda H; Nasu S; Yasuda S; Yasuda M; Ide M
Int J Gynecol Cancer; 2006; 16 Suppl 1():99-107. PubMed ID: 16515575
[TBL] [Abstract][Full Text] [Related]
36. Determining diagnosis date of diabetes using structured electronic health record (EHR) data: the SEARCH for diabetes in youth study.
Lenoir KM; Wagenknecht LE; Divers J; Casanova R; Dabelea D; Saydah S; Pihoker C; Liese AD; Standiford D; Hamman R; Wells BJ;
BMC Med Res Methodol; 2021 Oct; 21(1):210. PubMed ID: 34629073
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
Roze JF; Hoogendam JP; van de Wetering FT; Spijker R; Verleye L; Vlayen J; Veldhuis WB; Scholten RJ; Zweemer RP
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012567. PubMed ID: 30298516
[TBL] [Abstract][Full Text] [Related]
38. Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.
Gadducci A; Simonetti E; Guidoccio F; Manca G; Giorgetti A; Depalo T; Cosio S; Miccoli M; Volterrani D
Anticancer Res; 2021 Apr; 41(4):1937-1944. PubMed ID: 33813399
[TBL] [Abstract][Full Text] [Related]
39. Identification of asthma control factor in clinical notes using a hybrid deep learning model.
Agnikula Kshatriya BS; Sagheb E; Wi CI; Yoon J; Seol HY; Juhn Y; Sohn S
BMC Med Inform Decis Mak; 2021 Nov; 21(Suppl 7):272. PubMed ID: 34753481
[TBL] [Abstract][Full Text] [Related]
40. Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
Kalash R; Glaser SM; Rangaswamy B; Horne ZD; Kim H; Houser C; Beriwal S
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1008-1013. PubMed ID: 29559287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
